Antibody-exatecan conjugates with a novel self-immolative moiety overcome resistance in colon and lung cancer.
Cancer Discov. 2023 Jan 24:CD-22-1368. doi: 10.1158/2159-8290.CD-22-1368. Online ahead of print.
Cancer Discov. 2023.
PMID: 36693125